Group One Trading, L.P. Affimed N.V. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.32 - $0.62 $64 - $124	-200 Reduced 4.16%	4,609 $2,000
Q3 2023 Nov 09, 2023	SELL	$0.46 - $0.65 $543 - $768	-1,182 Reduced 19.73%	4,809 $2,000
Q2 2023 Aug 09, 2023	SELL	$0.57 - $1.08 $4,663 - $8,835	-8,181 Reduced 57.73%	5,991 $3,000
Q1 2023 May 12, 2023	SELL	$0.66 - $1.29 $4,485 - $8,766	-6,796 Reduced 32.41%	14,172 $10,000
Q4 2022 Feb 09, 2023	SELL	$1.1 - $2.45 $95,850 - $213,485	-87,137 Reduced 80.6%	20,968 $26,000
Q3 2022 Nov 09, 2022	BUY	$1.96 - $3.32 $51,708 - $87,588	26,382 Added 32.28%	108,105 $223,000
Q2 2022 Aug 11, 2022	BUY	$2.27 - $4.86 $105,856 - $226,636	46,633 Added 132.9%	81,723 $226,000
Q1 2022 May 12, 2022	BUY	$3.69 - $5.65 $25,881 - $39,629	7,014 Added 24.98%	35,090 $153,000
Q4 2021 Feb 11, 2022	BUY	$5.37 - $7.07 $150,768 - $198,497	28,076 New	28,076 $155,000
Q1 2021 May 12, 2021	SELL	$5.12 - $8.48 $30,771 - $50,964	-6,010 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$3.16 - $7.03 $8,102 - $18,024	-2,564 Reduced 29.9%	6,010 $35,000
Q3 2020 Nov 12, 2020	BUY	$3.26 - $4.73 $27,344 - $39,675	8,388 Added 4509.68%	8,574 $29,000
Q2 2020 Aug 13, 2020	SELL	$1.58 - $4.63 $17,538 - $51,393	-11,100 Reduced 98.35%	186 $1,000
Q1 2020 May 13, 2020	BUY	$1.44 - $3.02 $16,251 - $34,083	11,286 New	11,286 $18,000
Q2 2019 Aug 09, 2019	SELL	$2.6 - $4.21 $96,460 - $156,191	-37,100 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.05 - $4.34 $75,679 - $107,688	24,813 Added 201.95%	37,100 $156,000
Q4 2018 Feb 06, 2019	SELL	$2.82 - $4.67 $127,878 - $211,770	-45,347 Reduced 78.68%	12,287 $38,000
Q3 2018 Nov 08, 2018	BUY	$1.45 - $6.15 $83,569 - $354,449	57,634 New	57,634 $251,000
Q2 2018 Aug 14, 2018	SELL	$1.65 - $2.5 $3,300 - $5,000	-2,000 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$1.25 - $2.65 $2,976 - $6,309	-2,381 Reduced 54.35%	2,000 $4,000
Q3 2017 Nov 15, 2017	SELL	$1.95 - $2.25 $14,077 - $16,242	-7,219 Reduced 62.23%	4,381 $10,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,600	11,600 $24,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

Tekla Capital Management LLC

586K
Shares

$2.04 Million
0.01% of portfolio
Act Capital Management, LLC Wayne, PA

309K
Shares

$1.07 Million
0.88% of portfolio
Telemetry Investments, L.L.C. New York, NY

200K
Shares

$696,000
0.39% of portfolio

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account